A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection

Journal of Infection

Volumn 46, Issue 2, 2003, Pages 94-100

  Farrell, D J ^a   Morrissey, I ^a   de Rubeis, D ^a   Robbins, M ^a   Felmingham, D ^a  

^a GR Micro   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFRADINE; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; ENTEROCOCCUS FAECALIS; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; PATHOGENICITY; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PROTEUS MIRABILIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; UNITED KINGDOM; URINARY TRACT INFECTION;

EID: 0037323019     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2002.1091     Document Type: Article

References (14)

1. Stamm WE, Hooton TM. The management of urinary tract infection. N Engl J Med 1993; 329: 1328-1334.
2. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745-758.
3. Gastmeier P. Nosocomial urinary tract infections: many unresolved questions. Clin Micro Infect 2001; 7: 521-522.
4. Nicolle LE, Strausbaugh LJ, Garibaldi RA. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev 1996; 9: 1-17.
5. Grüneberg RN. Changes in urinary pathogens and their antibiotic sensitivities. 1971-1992. J Antimicrob Chemother 1994; 33(Suppl. A): 1-8.
6. MacGowan AP, Brown NM, Holt HA, Lovering AM, McCulloch SY, Reeves DS. An eight-year survey of the antimicrobial susceptibility patterns of 85,971 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother 1993; 31: 543-557.
7. Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB. Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 1999; 44: 359-365.
8. Mathai D, Jones RN, Pfaller MA. Epidemiology and frequency of resistance among pathogens causing urinary tract infection in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diag Microbiol Infect Dis 2001; 40: 129-136.
9. Karlowsky JA, Jones ME, Thornsberry C, Critchley I, Kelly L, Sahm D. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrob Agents 2001; 18: 121-127.
10. NCCLS (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard-5th edn. NCCLS document M7-A5 (ISBN 1-56238-394-9). NCCLS, Wayne, Pennsylvania 19087-1898, USA.
11. NCCLS (2002). Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement. NCCLS document M100-12 (ISBN 1-56238-454-6) NCCLS, Wayne, Pennsylvania 19087-1898, USA.
12. Kahlmeter G. The ECO-SENS project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens. J Antimicrob Chemother 2000; 46(Suppl. S1): 15-22.
13. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; 281: 736-738.
14. Blondeau JM, Yaschuk Y, Suter M, Vaughan D, and the Canadian Antimicrobial Study Group. In-vitro susceptibility of 1982 respiratory pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. J Antimicrobial Chemotherapy 1999; 43(Suppl. A): 3-23.